Monthly Archives: September 2015

Real World Evidence Making Headlines

Click here to subscribe to SVMPharma’s RWE updates

Latest Updates

Combatting COVID-19 with real-world evidence
FDA see expanded role for real-world evidence (RWE); Merck KGaA and Pfizer generate RWE for regulatory submission
Synapse and FDA collaborate to swiftly generate real-world data (RWD) in COVID-19 patients with cancer
Real-world evidence supports CAR-T-cell therapy’s safety and efficacy
NICE and Flatiron partner to utilise real-world oncology data in informing decisions about cancer therapy access

Quick Links

Real World Evidence
Global Real World Evidence
Additional Services
Privacy Policy
Contact Us

About SVMPharma

SVMPharma is a bespoke strategic consultancy based in Hampshire UK, specialising in Real World Evidence (RWE) for the pharmaceutical and healthcare industries. At SVMPharma we also cover Global RWE, Patient Experience, Big Data Analytics and Influence Mapping alongside Additional Services. Find further information and read our latest articles in the Resource Centre.

+44 (0)1252 964650

Quick Links

Real World Evidence
Global Real World Evidence
Additional Services
Privacy Policy
Contact Us

Twitter

Tweets by @SVMPharma

Latest News

UCB acquires new campus to support UK operations October 19, 2020
AbbVie’s Venclexta granted full US approval in AML October 19, 2020
ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’ October 19, 2020
Ten new medicines backed for EU approval October 19, 2020
CQC assessment is a ‘wake-up call’ to government, says NHS Confed chief exec October 16, 2020

Privacy Policy
Website Disclaimer
Sitemap